Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

299.61
Delayed Data
As of Sep 02
 +5.40 / +1.84%
Today’s Change
208.64
Today|||52-Week Range
340.34
+16.39%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$115.8B

Company Description

Allergan Plc operates as an investment holding company. It is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand, brand generic, over-the-counter and biosimilar products. The company operates through the following segments: North American Brands, North American Generics and International, and Anda. The company was founded on October 1, 2013 and is headquartered in Dublin, Ireland.

Contact Information

Allergan Plc
1 Grand Canal Square
Dublin Dublin 2
P:3538622617000
Investor Relations:
(862) 261-7152

Employees

Shareholders

Mutual fund holders44.82%
Other institutional44.61%
Individual stakeholders0.12%

Top Executives

Brenton L. SaundersPresident, Chief Executive Officer & Director
Robert A. StewartChief Operating Officer
Maria Teresa HiladoChief Financial Officer
Jonathon KellermanGlobal Chief Compliance Officer & Executive VP
Karen L. LingChief Human Resources Officer & Executive VP